Taoka Chemical Company, Limited posts a EBIT of $1.4B as of June 2026. That compares with $2.1B in the prior-year period — down 31.6% year over year. That is above the sector sector average of $-25M. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Taoka Chemical Company, Limited's EBIT was $2.1B. The latest reading is $1.4B — a 31.6% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a EBIT near $-25M is typical. Taoka Chemical Company, Limited's $1.4B is higher that level. That is roughly 5814.6% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

EBIT is one piece of Taoka Chemical Company, Limited's financial statement story. At $1.4B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for 4113.T's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $-25M), and (3) consistency with growth and profitability. This page covers the first two; Taoka Chemical Company, Limited's other metric pages and overview cover the third.